Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Simvastatin: two decades in a circle.
Riluzole enhances glutamate uptake in rat astrocyte cultures.
Quantitative structure-activity relationship studies on sulfonamide-based MMP inhibitors.
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
Discovery of Biologically Active Oncologic and Immunologic Small Molecule Therapies using Zebrafish: Overview and Example of Modulation of T Cell Activation.
The nocebo effect: A clinicians guide.
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
Longitudinal extensive transverse myelitis and optic neuritis: the elements for the diagnosis of neuromyelitis optica.
In vivo vs. ex vivo Magnetic Resonance Imaging In Mice.
Optic Neuritis Probably Induced by Isotretinoin.
FDA approves first oral drug to reduce MS relapses
A Patient with Leiden V Mutation, Multiple Sclerosis, Psoriasis, and Sicca Syndrome: Could Celecoxib and Fingolimod Adversely Affect the Heart?
Short and long term variation in ultraviolet radiation and multiple sclerosis.
Back on the scent: the olfactory system in CNS demyelinating diseases.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
MSer – A new, neutral descriptor for someone with multiple sclerosis
Social cognition in pediatric-onset multiple sclerosis (MS).
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.
Th17 Cells in Neuromyelitis Optica Spectrum Disorder: A review.
Disclosing the diagnosis of multiple sclerosis: The Profile Project.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

Pages